Daihan Pharmaceutical Co.,Ltd. (KOSDAQ: 023910)

South Korea flag South Korea · Delayed Price · Currency is KRW
26,050
0.00 (0.00%)
Jan 22, 2025, 3:00 PM KST
-5.79%
Market Cap 153.17B
Revenue (ttm) 201.97B
Net Income (ttm) 30.67B
Shares Out 5.88M
EPS (ttm) 5,215.14
PE Ratio 5.00
Forward PE n/a
Dividend 750.00 (2.88%)
Ex-Dividend Date Dec 27, 2024
Volume 5,524
Average Volume 4,532
Open 26,050
Previous Close 26,050
Day's Range 25,800 - 26,050
52-Week Range 23,750 - 29,650
Beta 0.19
RSI 46.11
Earnings Date Feb 7, 2025

About Daihan Pharmaceutical Co.,Ltd.

Daihan Pharmaceutical Co.,Ltd. engages in the manufacture and sale of therapeutic drugs in South Korea. The company offers various drugs, such as prescription, OTC, and quasi drugs, as well as offers various infusion related solutions. Daihan Pharmaceutical Co.,Ltd. was founded in 1945 and is headquartered in Seoul, South Korea. [Read more]

Industry Pharmaceutical Preparations
Founded 1945
Employees 553
Stock Exchange KOSDAQ
Ticker Symbol 023910
Full Company Profile

Financial Performance

In 2023, Daihan Pharmaceutical Co.,Ltd.'s revenue was 195.91 billion, an increase of 6.32% compared to the previous year's 184.27 billion. Earnings were 28.43 billion, an increase of 13.88%.

Financial Statements

News

There is no news available yet.